Literature DB >> 23188412

Follicular fluid hormonal profile and cumulus cell gene expression in controlled ovarian hyperstimulation with recombinant FSH: effects of recombinant LH administration.

Marzia Barberi1, Beatrice Ermini, Maria Beatrice Morelli, Michele Ermini, Sandra Cecconi, Rita Canipari.   

Abstract

PURPOSE: Down-regulation with gonadodropin-releasing agonist (GnRH-a) protocol during IVF stimulation leads to a severe endogenous LH suppression, which may affect the follicular development. The aim of the study was to evaluate the effects of recombinant LH (r-LH) administration, during late follicular development stages, in recombinant FSH (r-FSH) stimulated cycles on follicular fluid (FF) parameters and on cumulus cell quality.
METHODS: Twenty patients undergoing IVF were stimulated in a long GnRH agonist protocol with r-FSH alone or with r-LH supplementation when the leading follicle reached diameter of 14 mm. FF was collected at the time of oocyte retrieval from 32 follicles ≥ 18 mm. Serum FSH, LH, estradiol (E(2)), and progesterone (P(4)) were evaluated on the day of hCG administration. Intra-follicular E(2), P(4), AMH and TGF-β were assayed. Total RNA from 18 individual cumuli was isolated for gene expression analyses.
RESULTS: R-LH increased FF P(4) levels. FF TGF-β levels and PTGS2 and HAS2 expression in cumulus cells (CCs) positively correlated with increased P(4) levels observed in FFs, while a negative correlation was found between P(4) and AMH levels.
CONCLUSIONS: FF positive correlation between P(4) and TGF-β levels and CC expression of PTGS2 and HAS2 suggest an association with a better follicle quality. In addition, our data suggest that late follicular phase r-LH supplementation leads to a more advanced stage of follicular maturation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23188412      PMCID: PMC3528868          DOI: 10.1007/s10815-012-9893-9

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  61 in total

Review 1.  Endocrine and paracrine regulation of cumulus expansion.

Authors:  A Salustri; A Camaioni; C D'Alessandris
Journal:  Zygote       Date:  1996-11       Impact factor: 1.442

2.  Increase in transforming growth factor beta1 in ovarian follicular fluid following ovarian stimulation and in-vitro fertilization correlates to pregnancy.

Authors:  G Fried; H Wramsby
Journal:  Hum Reprod       Date:  1998-03       Impact factor: 6.918

3.  Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction.

Authors:  L G Westergaard; S B Laursen; C Y Andersen
Journal:  Hum Reprod       Date:  2000-05       Impact factor: 6.918

4.  Consequences of premature progesterone elevation on the outcome of in vitro fertilization: insights into a controversy.

Authors:  R Fanchin; C Righini; F Olivennes; A L Ferreira; D de Ziegler; R Frydman
Journal:  Fertil Steril       Date:  1997-11       Impact factor: 7.329

5.  Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques.

Authors:  Anna Pia Ferraretti; Luca Gianaroli; Maria C Magli; Arianna D'angelo; Valeria Farfalli; Nadia Montanaro
Journal:  Fertil Steril       Date:  2004-12       Impact factor: 7.329

6.  Paracrine actions of growth differentiation factor-9 in the mammalian ovary.

Authors:  J A Elvin; A T Clark; P Wang; N M Wolfman; M M Matzuk
Journal:  Mol Endocrinol       Date:  1999-06

7.  Human cumulus granulosa cell gene expression: a predictor of fertilization and embryo selection in women undergoing IVF.

Authors:  L J McKenzie; S A Pangas; S A Carson; E Kovanci; P Cisneros; J E Buster; P Amato; M M Matzuk
Journal:  Hum Reprod       Date:  2004-10-07       Impact factor: 6.918

8.  Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth.

Authors:  W M Baarends; J T Uilenbroek; P Kramer; J W Hoogerbrugge; E C van Leeuwen; A P Themmen; J A Grootegoed
Journal:  Endocrinology       Date:  1995-11       Impact factor: 4.736

9.  Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation.

Authors:  M W Sullivan; A Stewart-Akers; J S Krasnow; S L Berga; A J Zeleznik
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

10.  Transforming growth factor-beta1, insulin-like growth factors, and insulin-like growth factor binding proteins in ovarian follicular fluid are differentially regulated by the type of ovarian hyperstimulation used for in vitro fertilization.

Authors:  G Fried; H Wramsby; M Tally
Journal:  Fertil Steril       Date:  1998-07       Impact factor: 7.329

View more
  6 in total

1.  Recombinant LH supplementation during IVF cycles with a GnRH-antagonist in estimated poor responders: A cross-matched pilot investigation of the optimal daily dose and timing.

Authors:  Salvatore Gizzo; Alessandra Andrisani; Marco Noventa; Serena Manfè; Alessandra Oliva; Michele Gangemi; Giovanni Battista Nardelli; Guido Ambrosini
Journal:  Mol Med Rep       Date:  2015-06-09       Impact factor: 2.952

2.  Comparative Analysis of Porcine Follicular Fluid Proteomes of Small and Large Ovarian Follicles.

Authors:  Victor M Paes; José R de Figueiredo; Peter L Ryan; Scott T Willard; Jean M Feugang
Journal:  Biology (Basel)       Date:  2020-05-17

3.  Connective tissue growth factor mediates bone morphogenetic protein 2-induced increase in hyaluronan production in luteinized human granulosa cells.

Authors:  Hsun-Ming Chang; Long Bai; Yi-Min Zhu; Peter C K Leung
Journal:  Reprod Biol Endocrinol       Date:  2022-04-08       Impact factor: 5.211

4.  Recombinant LH supplementation improves cumulative live birth rates in the GnRH antagonist protocol: a multicenter retrospective study using a propensity score-matching analysis.

Authors:  Meng Wang; Rui Huang; Xiaoyan Liang; Yundong Mao; Wenhao Shi; Qian Li
Journal:  Reprod Biol Endocrinol       Date:  2022-08-08       Impact factor: 4.982

5.  A Comparison of Outcomes from In Vitro Fertilization Cycles Stimulated with Follicle Stimulating Hormone Plus either Recombinant Luteinizing Hormone or Human Menopausal Gonadotropins in Subjects Treated with Long Gonadotropin Releasing Hormone Agonist Protocols.

Authors:  Nathalie Bleau; Mohammed Agdi; WeonYoung Son; SeangLin Tan; Michael H Dahan
Journal:  Int J Fertil Steril       Date:  2017-02-16

6.  LH supplementation of ovarian stimulation protocols influences follicular fluid steroid composition contributing to the improvement of ovarian response in poor responder women.

Authors:  S Marchiani; L Tamburrino; S Pellegrini; E Baldi; F Benini; M Pallecchi; C Bignozzi; A Conforti; C Alviggi; L Vignozzi; G Danza
Journal:  Sci Rep       Date:  2020-07-31       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.